Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release

Journal of Virology

Volumn 79, Issue 15, 2005, Pages 9862-9871

  Choi, Keum S ^a   Aizaki, Hideki ^a   Lai, Michael M C ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b ACADEMIA SINICA   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; METHYL BETA CYCLODEXTRIN; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; CELL FUSION; CELL MATURATION; CELL MEMBRANE; CHOLESTEROL METABOLISM; CONTROLLED STUDY; CORONAVIRUS; GOLGI COMPLEX; HEPATITIS VIRUS; INTERNALIZATION; LIPID RAFT; MEMBRANE BINDING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; RECEPTOR BINDING; VIRUS CELL INTERACTION; VIRUS MORPHOLOGY; VIRUS SPIKE;

ANIMALS; CELL FUSION; CELL LINE; MEMBRANE GLYCOPROTEINS; MEMBRANE MICRODOMAINS; MICE; MURINE HEPATITIS VIRUS; TEMPERATURE; VIRAL ENVELOPE PROTEINS; VIRUS REPLICATION;

MURINE HEPATITIS VIRUS;

EID: 22544463108     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.79.15.9862-9871.2005     Document Type: Article

References (40)

1. Ahn, A., D. L. Gibbons, and M. Kielian. 2002. The fusion peptide of Semliki Forest virus associates with sterol-rich membrane domains. J. Virol. 76:3267-3275.
2. Ali, A., R. T. Avalos, E. Ponimaskin, and D. P. Nayak. 2000. Influenza virus assembly: effect of influenza virus glycoproteins on the membrane association of M1 protein. J. Virol. 74:8709-8719.
3. Bavari, S., C. M. Bosio, E. Wiegand, G. Ruthel, A. B. Will, T. W. Geisbert, M. Hevey, C. Schmaljohn, A. Schmaljohn, and M. J. Aman. 2002. Lipid raft microdomains: a gateway for compartmentalized trafficking of Ebola and Marburg viruses. J. Exp. Med. 195:593-602.
4. Bender, F. C., J. C. Whitbeck, M. Ponce de Leon, H. Lou, R. J. Eisenberg, and G. H. Cohen. 2003. Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry. J. Virol. 77:9542-9552.
5. Bock, J. B., J. Klumperman, S. Davanger, and R. H. Scheller. 1997. Syntaxin 6 functions in trans-Golgi network vesicle trafficking. Mol. Biol. Cell 8:1261-1271.
6. Braunwald, J., H. Nonnenmacher, C. A. Pereira, and A. Kirn. 1991. Increased susceptibility to mouse hepatitis virus type 3 (MHV3) infection induced by a hypercholesterolaemic diet with increased adsorption of MHV3 to primary hepatocyte cultures. Res. Virol. 142:5-15.
7. Brown, D. A., and E. London. 1998. Structure and origin of ordered lipid domains in biological membranes. J. Membr. Biol. 164:103-114.
8. Campbell, S. M., S. M. Crowe, and J. Mak. 2002. Virion-associated cholesterol is critical for the maintenance of HIV-1 structure and infectivity. AIDS 16:2253-2261.
9. Cerny, J., H. Stockinger, and V. Horejsi. 1996. Noncovalent associations of T lymphocyte surface proteins. Eur. J. Immunol. 26:2335-2343.
10. Chazal, N., and D. Gerlier. 2003. Virus entry, assembly, budding, and membrane rafts. Microbiol. Mol. Biol. Rev. 67:226-237.
11. Daya, M., M. Cervin, and R. Anderson. 1988. Cholesterol enhances mouse hepatitis virus-mediated cell fusion. Virology 163:276-283.
12. Del G. Real, S. Jimenez-Baranda, R. A. Lacalle, E. Mira, P. Lucas, C. Gomez-Mouton, A. C. Carrera, A. C. Martinez, and S. Manes. 2002. Blocking of HIV-1 infection by targeting CD4 to nonraft membrane domains. J. Exp. Med. 196:293-301.
13. Graham, D. R., E. Chertova, J. M. Hilburn, L. O. Arthur, and J. E. Hildreth 2003. Cholesterol depletion of human immunodeficiency virus type 1 and simian immunodeficiency virus with β-cyclodextrin inactivates and permeabilizes the virions: evidence for virion-associated lipid rafts. J. Virol. 77:8237-8248.
14. Harder, T., P. Scheiffele, P. Verkade, and K. Simons. 1998. Lipid domain structure of the plasma membrane revealed by patching of membrane components. J. Cell Biol. 141:929-942.
15. Harris, T. J., and C. H. Siu. 2002. Reciprocal raft-receptor interactions and the assembly of adhesion complexes. Bioessays 24:996-1003.
16. Hirano, N., K. Fujiwara, S. Hino, and M. Matumoto. 1974. Replication and plaque formation of mouse hepatitis virus (MHV-2) in mouse cell line DBT culture. Arch. Gesamte Virusforsch. 44:298-302.
17. gag associates with membrane domains that are largely resistant to Brij98 but sensitive to Triton X-100. J. Virol. 77:4805-4817.
18. Khimperman, J., J. K. Locker, A. Meijer, M. C. Horzinek, H. J. Geuze, and P. J. Rottier. 1994. Coronavirus M proteins accumulate in the Golgi complex beyond the site of virion budding. J. Virol. 68:6523-6534.
19. Kovbasnjuk, O., M. Edidin, and M. Donowitz. 2001. Role of lipid rafts in Shiga toxin 1 interaction with the apical surface of Caco-2 cells. J. Cell Sci. 114:4025-4031.
20. Kozak, S. L., J. M, Heard, and D, Kabat, 2002. Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus. J. Virol. 76:1802-1815.
21. Lee, A. 2001. Membrane structure. Curr. Biol. 11:R811-R814.
22. Marjomaki, V., V. Pietiainen, H. Matilainen, P. Upla, J. Ivaska, L. Nissinen, H. Reunanen, P. Huttunen, T. Hyypia, and J. Heino, 2002. Internalization of echovirus 1 in caveolae. J. Virol. 76:1856-1865.
23. Nomura, R., A, Kiyota, E. Suzaki, K. Kataoka, Y. Ohe, K. Miyamoto, T. Senda, and T. Fujimoto. 2004. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J. Virol. 78:8701-8708.
24. Ono, A., and E. O. Freed. 2001. Plasma membrane rafts play a critical role in HIV-1 assembly and release. Proc. Natl. Acad. Sci. USA 98:13925-13930.
25. Panchal, R. G., G. Ruthel, T. A. Kenny, G. H. Kallstrom, D. Lane, S. S. Badie, Li, L., S. Bavari, and M. J. Aman. 2003. In vivo oligomerization and raft localization of Ebola virus protein VP40 during vesicular budding. Proc. Natl. Acad. Sci. USA 100:15936-15941.
26. Parton, R. G., and M. Lindsay. 1999. Exploitation of major histocompatibility complex class I molecules and caveolae by simian virus 40. Immunol. Rev. 168:23-31.
27. Pickl, W. F., F. X. Pimentel-Muinos, and B. Seed. 2001. Lipid rafts and pseudotyping. J. Virol. 75:7175-7183.
28. + T cells. J. Virol. 76:4709-4722.
29. Rawat, S. S., M. Viard, S. A. Gallo, A. Rein, R. Blumenthal, and A. Puri. 2003. Modulation of entry of enveloped viruses by cholesterol and sphingolipids (Review). Mol. Membr. Biol. 20:243-254.
30. Scheiffele, P., A. Rietveld, T. Wilk, and K. Simons. 1999. Influenza viruses select ordered lipid domains during budding from the plasma membrane. J. Biol. Chem. 274:2038-2044.
31. Scheiffele, P., M. G. Roth, and K. Simons. 1997. Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain. EMBO J. 16:5501-5508.
32. Simons, K., and E. Ikonen. 1997. Functional rafts in cell membranes. Nature 387:569-572.
33. Simons, K., and E. Ikonen. 2000. How cells handle cholesterol. Science 290:1721-1726.
34. Simons, K., and D. Toomre. 2000. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 1:31-39.
35. Singer, S. J., and G. L. Nicolson. 1972. The fluid mosaic model of the structure of cell membranes. Science 175:720-731.
36. Suomalainen, M. 2002. Lipid rafts and assembly of enveloped viruses. Traffic 3:705-709.
37. Thorp, E. B., and T. M. Gallagher. 2004. Requirements for CEACAMs and cholesterol during murine coronavirus cell entry. J. Virol. 78:2682-2692.
38. Tsui-Pierchala, B. A., M. Encinas, J. Milbrandt, and E. M. Johnson, Jr. 2002. Lipid rafts in neuronal signaling and function. Trends Neurosci. 25:412-417.
39. Vincent, S., D. Gerlier, and S. N. Manie. 2000. Measles virus assembly within membrane rafts. J. Virol. 74:9911-9915.
40. Yokomori, K., and M. M. C. Lai. 1992. The receptor for mouse hepatitis virus in the resistant mouse strain SJL is functional: implications for the requirement of a second factor for viral infection. J. Virol. 66:6931-6938.